Cefriv T 250mg/31.25mg Injection
Marketer
Fedley Healthcare Private Limited
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefriv T 250mg/31.25mg Injection
Cefriv T 250mg/31.25mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism halts microbial proliferation, thereby controlling infection spread. Administration must be strictly under medical guidance; adherence to the prescribed schedule is crucial. Complete the entire course, regardless of symptom improvement, as premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek immediate help for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are essential for optimal recovery. Your doctor may order tests to monitor the medication's effects.
Uses of Cefriv T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cefriv T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cefriv T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefriv T 250mg/31.25mg Injection:
This medication will be administered by your physician or their qualified staff; please do not attempt self-medication.
How Cefriv T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefriv T 250mg/31.25mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to multiply. Tazobactum, a beta-lactamase inhibitor, complements Ceftriaxone by countering bacterial resistance mechanisms, thereby maximizing the antibiotic's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Cefriv T 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
Cefriv T 250mg/31.25mg injections are typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
The administration of Cefriv T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until the maternal course of treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Cefriv T 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Cefriv T 250mg/31.25mg Injection use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Cefriv T 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage alteration for Cefriv T 250mg/31.25mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefriv T 250mg/31.25mg Injection :
Should you forget a scheduled dose of Cefriv T 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Cefriv T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently